Annual Revenue
$37.43 M
+$21.66 M+137.45%
December 31, 2021
Summary
- As of February 10, 2025, EPZM annual revenue is $37.43 million, with the most recent change of +$21.66 million (+137.45%) on December 31, 2021.
- During the last 3 years, EPZM annual revenue has risen by +$15.73 million (+72.47%).
Performance
EPZM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Revenue
$27.53 M
+$18.83 M+216.56%
June 30, 2022
Summary
- As of February 10, 2025, EPZM quarterly revenue is $27.53 million, with the most recent change of +$18.83 million (+216.56%) on June 30, 2022.
- Over the past year, EPZM quarterly revenue has increased by +$14.52 million (+111.59%).
Performance
EPZM Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
$53.01 M
+$14.52 M+37.72%
June 30, 2022
Summary
- As of February 10, 2025, EPZM TTM revenue is $53.01 million, with the most recent change of +$14.52 million (+37.72%) on June 30, 2022.
- Over the past year, EPZM TTM revenue has increased by +$20.43 million (+62.69%).
Performance
EPZM TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EPZM Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +137.4% | +111.6% | +62.7% |
| 3 y3 years | +72.5% | +366.6% | +122.7% |
| 5 y5 years | +274.3% | +175.3% | +122.7% |
EPZM Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | -68.4% | at high | -29.4% |
| 5 y | 5-year | at high | -57.9% | at high | -95.1% | at high | -78.0% |
| alltime | all time | -45.3% | -93.2% | -24.2% | -98.7% | -27.4% | -96.5% |
Epizyme Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $27.53 M(+216.6%) | $53.01 M(+37.7%) |
| Mar 2022 | - | $8.70 M(-24.9%) | $38.49 M(+2.8%) |
| Dec 2021 | $37.43 M(+137.5%) | $11.58 M(+122.7%) | $37.42 M(+9.4%) |
| Sep 2021 | - | $5.20 M(-60.0%) | $34.22 M(+5.0%) |
| Jun 2021 | - | $13.01 M(+70.5%) | $32.58 M(+47.8%) |
| Mar 2021 | - | $7.63 M(-8.9%) | $22.04 M(+39.8%) |
| Dec 2020 | $15.76 M(-33.8%) | $8.38 M(+134.9%) | $15.76 M(+34.9%) |
| Sep 2020 | - | $3.57 M(+44.5%) | $11.68 M(-15.5%) |
| Jun 2020 | - | $2.47 M(+82.2%) | $13.83 M(-19.9%) |
| Mar 2020 | - | $1.35 M(-68.5%) | $17.26 M(-27.5%) |
| Dec 2019 | $23.80 M(+9.7%) | $4.29 M(-24.9%) | $23.80 M(-18.5%) |
| Sep 2019 | - | $5.71 M(-3.1%) | $29.21 M(+24.3%) |
| Jun 2019 | - | $5.90 M(-25.2%) | $23.49 M(-20.6%) |
| Mar 2019 | - | $7.89 M(-18.6%) | $29.59 M(+36.4%) |
| Dec 2018 | $21.70 M(+117.0%) | $9.70 M(-19.2%) | $21.70 M(+80.8%) |
| Jun 2018 | - | $12.00 M(+20.0%) | $12.00 M(-29.7%) |
| Dec 2017 | $10.00 M(+24.9%) | - | - |
| Jun 2017 | - | $10.00 M(+1992.1%) | $17.06 M(+113.1%) |
| Dec 2016 | $8.01 M | $478.00 K(-92.7%) | $8.01 M(-1.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | - | $6.58 M(+1292.0%) | $8.08 M(+335.1%) |
| Jun 2016 | - | $473.00 K(+0.2%) | $1.86 M(-12.4%) |
| Mar 2016 | - | $472.00 K(-15.0%) | $2.12 M(-17.1%) |
| Dec 2015 | $2.56 M(-93.8%) | $555.00 K(+55.0%) | $2.56 M(-79.3%) |
| Sep 2015 | - | $358.00 K(-51.4%) | $12.35 M(-38.8%) |
| Jun 2015 | - | $736.00 K(-19.2%) | $20.17 M(-30.3%) |
| Mar 2015 | - | $911.00 K(-91.2%) | $28.93 M(-30.1%) |
| Dec 2014 | $41.41 M(-39.5%) | $10.35 M(+26.6%) | $41.41 M(-38.5%) |
| Sep 2014 | - | $8.18 M(-13.9%) | $67.38 M(-0.4%) |
| Jun 2014 | - | $9.49 M(-29.1%) | $67.65 M(-7.3%) |
| Mar 2014 | - | $13.39 M(-63.1%) | $72.99 M(+6.6%) |
| Dec 2013 | $68.48 M(+51.4%) | $36.32 M(+330.1%) | $68.48 M(+66.8%) |
| Sep 2013 | - | $8.44 M(-43.1%) | $41.06 M(-14.4%) |
| Jun 2013 | - | $14.84 M(+67.1%) | $47.95 M(-1.0%) |
| Mar 2013 | - | $8.88 M(-0.1%) | $48.45 M(+7.1%) |
| Dec 2012 | $45.22 M(+551.2%) | $8.89 M(-42.0%) | $45.22 M(+24.5%) |
| Sep 2012 | - | $15.33 M(-0.1%) | $36.33 M(+73.0%) |
| Jun 2012 | - | $15.34 M(+171.3%) | $21.00 M(+271.3%) |
| Mar 2012 | - | $5.65 M | $5.65 M |
| Dec 2011 | $6.94 M | - | - |
FAQ
- What is Epizyme annual revenue?
- What is the all time high annual revenue for Epizyme?
- What is Epizyme annual revenue year-on-year change?
- What is Epizyme quarterly revenue?
- What is the all time high quarterly revenue for Epizyme?
- What is Epizyme quarterly revenue year-on-year change?
- What is Epizyme TTM revenue?
- What is the all time high TTM revenue for Epizyme?
- What is Epizyme TTM revenue year-on-year change?
What is Epizyme annual revenue?
The current annual revenue of EPZM is $37.43 M
What is the all time high annual revenue for Epizyme?
Epizyme all-time high annual revenue is $68.48 M
What is Epizyme annual revenue year-on-year change?
Over the past year, EPZM annual revenue has changed by +$21.66 M (+137.45%)
What is Epizyme quarterly revenue?
The current quarterly revenue of EPZM is $27.53 M
What is the all time high quarterly revenue for Epizyme?
Epizyme all-time high quarterly revenue is $36.32 M
What is Epizyme quarterly revenue year-on-year change?
Over the past year, EPZM quarterly revenue has changed by +$14.52 M (+111.59%)
What is Epizyme TTM revenue?
The current TTM revenue of EPZM is $53.01 M
What is the all time high TTM revenue for Epizyme?
Epizyme all-time high TTM revenue is $72.99 M
What is Epizyme TTM revenue year-on-year change?
Over the past year, EPZM TTM revenue has changed by +$20.43 M (+62.69%)